ASRS Screener — Adult ADHD Self-Report Scale

The Adult ADHD Self-Report Scale, version 1.1 (ASRS-v1.1) is an 18-item self-report instrument developed by Kessler and colleagues in 2005 in collaboration with the World Health Organization. Each item maps directly to one of the 18 DSM-IV/DSM-5 ADHD symptom criteria, rated on a 5-point frequency scale (Never / Rarely / Sometimes / Often / Very Often) over the past 6 months. Within the 18 items, six items form the optimized 6-item ASRS Screener — the brief detection subset Kessler 2005 identified as the strongest screening combination. The instrument is in the public domain and is the most widely cited brief adult ADHD screener globally.

The instrument is sometimes called simply "the ASRS" or "the 18-item ASRS." When people refer to "the ASRS Screener" specifically, they often mean the brief 6-item version embedded inside the full 18-item form. Both versions share the same items and the same response scale; they differ in scoring and what they're optimized for.

The ASRS exists at the intersection of three properties that make it the canonical adult ADHD screening tool: (a) cleanest licensing — WHO public domain, free for all uses; (b) brevity — 18 items in approximately 5 minutes; and (c) direct DSM mapping — each item corresponds 1:1 to a DSM symptom criterion, supporting both screening and clinical interpretation.

The ASRS matters because it is the bridge between the recognition that adult ADHD is real and consequential, and the practical work of getting people who have it into evaluation and treatment. Before the ASRS, brief adult ADHD screening relied on instruments that were proprietary, long, or both — the Conners' Adult ADHD Rating Scale at 66 items, the Brown ADD Scales at 40 items. Neither was suitable for population-level epidemiology or for self-screening at scale.

The ASRS was designed for the World Mental Health Survey Initiative — the WHO project that produced the first comparable global estimates of mental disorder prevalence across countries. The same instrument that supports population epidemiology also serves clinical screening, primary-care referral decisions, and consumer self-screening. This dual role — epidemiology AND practice — is unusual and is part of why the ASRS achieved its dominant position.

Practically: the ASRS is what produces the best US adult ADHD prevalence estimate (4.4% per Kessler 2006), what most adult ADHD research uses as the entry-point screening instrument, and what most consumer adult ADHD tests (this one included) are based on. Understanding the ASRS is understanding the empirical foundation of contemporary adult ADHD care.

The ASRS was developed by Ronald Kessler at Harvard's Department of Health Care Policy in collaboration with the World Health Organization, for use in the World Mental Health Survey Initiative — the WHO project producing the first internationally comparable estimates of psychiatric disorder prevalence. The development paper:

Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Secnik K, Spencer T, Ustun TB, Walters EE. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychological Medicine. 2005;35(2):245–256. doi:10.1017/s0033291704002892

The development sample drew from the National Comorbidity Survey Replication (NCS-R), a US household survey with structured diagnostic interviews. A subsample of n=966 was used to examine the operating characteristics of candidate item subsets against the DSM-IV ADHD diagnosis. A separate clinical sample of n=154 adults with confirmed ADHD diagnoses provided the comparison anchor.

The Kessler 2005 paper documented two interrelated findings. First, all 18 items mapping to DSM-IV criteria function as an internally consistent scale (Cronbach α ≈ 0.84). Second, a 6-item subset of the 18 items achieves the strongest brief classification performance with item-specific cutoffs — the "ASRS Screener" within the larger ASRS scale. The 6-item subset is items 1, 2, 3, 4, 7, 8 in DSM-symptom mapping — or, as more commonly numbered in clinical implementations, items 1 through 6 of the ordered instrument.

The instrument has since been used in dozens of large-scale epidemiological studies, including all subsequent WHO World Mental Health surveys, the National Comorbidity Survey Replication, the Australian National Survey of Mental Health and Wellbeing, and parallel surveys in Europe, Asia, and South America. Across these samples, the basic two-factor structure (Inattention + Hyperactivity-Impulsivity) replicates reliably.

The 18 items map to the 18 DSM-IV/DSM-5 ADHD symptom criteria — 9 inattention items mapping to DSM criterion A1, and 9 hyperactivity-impulsivity items mapping to criterion A2. Each item is rated 0–4 on a 5-point frequency scale (Never / Rarely / Sometimes / Often / Very Often) referenced to the past 6 months. Items 1–6 (marked ★ below) form the optimized 6-item screener.

Subscale structure

• Inattention subscale — items 1, 2, 3, 4, 7, 8, 9, 10, 11 (n=9). Range 0–36.
• Hyperactivity-Impulsivity subscale — items 5, 6, 12, 13, 14, 15, 16, 17, 18 (n=9). Range 0–36.
• Total score — sum of all 18 items. Range 0–72.
• 6-item ASRS Screener subset — items 1, 2, 3, 4 (Inattention) and items 5, 6 (Hyperactivity). Note that the screener is heavily inattention-weighted: 4 of 6 items are inattention, only 2 are hyperactivity.

Two scoring rules are used in parallel: a continuous total score from the full 18 items, and a binary classification from the 6-item screener subset.

Continuous total scoring

Each item is scored 0 (Never), 1 (Rarely), 2 (Sometimes), 3 (Often), 4 (Very Often). The total is the sum across all 18 items, range 0–72. Subscale sums are computed for Inattention (items 1, 2, 3, 4, 7, 8, 9, 10, 11) and Hyperactivity-Impulsivity (items 5, 6, 12, 13, 14, 15, 16, 17, 18), each ranging 0–36. There is no published clinical-consensus severity band system — the instrument was designed for binary screening, not severity grading. Score interpretation is typically done relative to population norms (Kessler 2005 US adult mean = 16.7, SD = 9.0).

6-item screener binary classification

The 6-item screener uses item-specific cutoffs from Kessler 2005. A response is "positive" if it meets or exceeds the item's cutoff. Four or more positive items overall indicates a positive screener.

Internal consistency

Cronbach's α for the full 18-item scale is consistently in the 0.84–0.93 range across published samples (Kessler 2005 development sample; Adler 2006 clinical replication; de Vries 2014 Dutch validation). Subscale α values are typically 0.78–0.88 for Inattention and 0.81–0.90 for Hyperactivity-Impulsivity. These values support the use of both full-scale and subscale scores.

Diagnostic accuracy of the 6-item screener

Performance varies substantially with sample composition. The Kessler 2005 specificity of 99.5% reflects the low base rate of ADHD in the general population (approximately 4.4%). In high-base-rate samples (psychiatric outpatients), specificity drops as expected because the prior probability of ADHD is higher. Sensitivity ranges 68–88% across samples.

Test-retest reliability

Test-retest correlation has been reported in the 0.85–0.88 range over 1–4 week intervals (Adler 2006). The instrument is appropriate for one-time screening, and repeated administration in short windows shows minimal practice effects.

Convergent validity

The ASRS-v1.1 correlates moderately to strongly with longer ADHD instruments — Conners' Adult ADHD Rating Scale (r ≈ 0.66–0.78), Brown ADD Scales (r ≈ 0.60–0.72), and the WHO Disability Assessment Schedule (r ≈ 0.40–0.55). The correlations support construct validity for the adult ADHD construct without indicating redundancy with proprietary instruments.

Cross-cultural validity

The ASRS has been translated into 35+ languages. Validation studies in Dutch, German, Spanish, French, Japanese, Mandarin Chinese, and Portuguese populations replicate the two-factor structure (Inattention + Hyperactivity-Impulsivity) and show acceptable internal consistency. Sex differences in mean scores are small but consistently in the direction of slightly higher male hyperactivity-impulsivity and slightly higher female inattention — consistent with the broader epidemiology.

The norms below anchor a respondent's score against published population samples. The general-population norm anchors comparison to adults not seeking help; the clinical norm anchors to adults with confirmed ADHD diagnoses. The key intuition: a score around 36 puts a respondent at the diagnosed-ADHD mean.

The roughly 20-point gap between general-population mean (16.7) and confirmed-ADHD mean (36.4) is the source signal that supports using the ASRS for screening: scores in the moderate range (~36) place a respondent in the same numerical territory as adults with confirmed diagnoses, providing strong (but not conclusive) probabilistic evidence.

It is a screen, not a diagnostic tool

The most important limitation. A positive screen indicates that ADHD-symptom levels warrant clinical attention. It does not constitute a diagnosis. Only a qualified clinician can diagnose ADHD via a comprehensive evaluation that addresses all five DSM-5 criteria: symptom thresholds, childhood-onset, multiple settings, functional impairment, and exclusion of better-explanation by another condition.

It does not assess childhood-onset

DSM-5 requires evidence of ADHD symptoms before age 12 for adult diagnosis. The ASRS asks only about the past 6 months. A high score with no childhood-symptom history points to alternative explanations (depression, anxiety, sleep disorders, head injury, perimenopause, thyroid dysfunction, chronic stress) rather than primary ADHD.

It does not assess functional impairment

DSM-5 requires that symptoms cause significant functional impairment in two or more settings. The ASRS does not include functional-impairment items (unlike the PHQ-9, which has a 10th item asking how much symptoms have affected work, home, or social life). A high symptom score without significant functional impact may not warrant clinical diagnosis.

It does not screen for comorbidities

Adult ADHD has high comorbidity with depression (~19%), anxiety (~24%), sleep disorders (~25%), and substance use (~15%) per Kessler 2006. The ASRS screens only for ADHD-symptom domains; a comprehensive evaluation should add screens for these common companions.

The 6-item screener is inattention-weighted

Of the 6 items in the screener subset, 4 are inattention items and only 2 are hyperactivity-impulsivity items. This weighting is appropriate for adult populations (where the inattentive presentation is more common than the hyperactive presentation) but means the brief screener under-detects pure-hyperactive presentations. The full 18-item form does not have this asymmetry.

Self-report is subject to bias

Like all self-report instruments, the ASRS is subject to insight limitations, social desirability bias, and recall bias. Adults with ADHD sometimes under-report (because attention difficulties feel "normal" and familiar) and sometimes over-report (when seeking diagnosis to access treatment). Informant ratings (partner, family) and clinician observation provide complementary perspectives that this self-screen cannot.

Past-6-months reference window

The instrument captures current functioning over the past 6 months. It does not capture trait-level ADHD vulnerability across the lifespan, nor does it distinguish current ADHD from a recent episode of depression that produces ADHD-like attention symptoms. This is one reason childhood-onset documentation matters for clinical interpretation.

The ASRS is the right choice for self-screening, primary-care screening, and population epidemiology. Other instruments serve different purposes.

For most adult ADHD self-screening contexts, the ASRS is the right starting point. If the ASRS screens positive, a clinician may use the Conners' or Brown scales as part of a more comprehensive evaluation. The WURS is the natural complement to the ASRS for the childhood-onset criterion: WURS for childhood symptoms, ASRS for current symptoms.

Other LifeByLogic glossary entries that connect to the ASRS Screener.